Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

CDSCO Expert Panel Accepts Phase IV Safety Data for Eisai Pharmas Lenvatinib Capsules

Emcure Pharma to distribute, promote Sanofi oral anti-diabetic drugs in India

Ruchika Sharma17 July 2025 3:22 PM IST

Mumbai: Emcure Pharmaceuticals Ltd. and Sanofi India Limited have entered into an exclusive distribution and promotion agreement...

Novo Nordisk concludes acquisition of Akero Therapeutics

CORONA Remedies buys 7 brands from Bayer pharma division in India

Ruchika Sharma17 July 2025 2:52 PM IST

Ahmedabad: CORONA Remedies has announced the acquisition of seven brands from the pharmaceutical division of Bayer in India.Effective July 16, 2025,...

CDSCO Panel Backs Label Change Allowing Endocrinologists, Rheumatologists to Prescribe Amgens Romosozumab

GSK Shingrix approved by USFDA in prefilled syringe presentation

Ruchika Sharma17 July 2025 2:19 PM IST

London: GSK plc has received approval from the US Food and Drug Administration (FDA) for a prefilled syringe presentation of Shingrix (GSK's...

Novartis names Mukul Mehta as CFO

Ruchika Sharma17 July 2025 12:46 PM IST

Basel: Novartis has announced the appointment of Mukul Mehta as the Chief Financial Officer (CFO) and a member of the Executive Committee of...

Sanofi India names Rachid Ayari as Interim MD

Sanofi India appoints Rachid Ayari as Interim MD

Ruchika Sharma17 July 2025 12:05 PM IST

Mumbai: Sanofi India has appointed Rachid Ayari as its Interim Managing Director, while continuing in his current role as Chief Financial Officer...

Zydus Matoda facility completes USFDA Remote Regulatory Assessment

Ruchika Sharma17 July 2025 11:24 AM IST

Ahmedabad: Zydus Lifesciences has announced that the U.S. Food and Drug Administration (USFDA) has conducted a Remote Regulatory Assessment (RRA)...

PLI Schemes reduce API import dependence: Govt tells Parliament

20 lakh tablets seized in biggest pharma drug haul in Lucknow

Ruchika Sharma17 July 2025 10:30 AM IST

Lucknow: The Central Bureau of Narcotics (CBN), Lucknow Zone, has recovered nearly 20 lakh tablets of controlled medicines and 5,700 bottles...

Lupin gets USFDA EIR for Pithampur Unit 3 facility

Lupin rolls out Loteprednol Etabonate Ophthalmic Suspension, 0.5% in US

Ruchika Sharma16 July 2025 5:04 PM IST

Mumbai: Global pharma major Lupin Limited has launched Loteprednol Etabonate Ophthalmic Suspension, 0.5%, in the United States,...

GSK Nucala receives positive EMA Committee opinion for COPD

GSK blood cancer drug Blenrep faces USFDA scrutiny over vision issues

Ruchika Sharma16 July 2025 4:15 PM IST

GSK's blood cancer drug, Blenrep, is under the U.S. Food and Drug Administration (USFDA) spotlight, as staff reviewers raised safety concerns on...

First patient randomized in Ropanicant Phase 2b trial for Major Depressive Disorder: Suven Life Sciences

Ruchika Sharma16 July 2025 2:47 PM IST

Hyderabad: Suven Life Sciences has announced that the first patient has been randomized in its Phase-2b clinical trial evaluating Ropanicant, a...

Sanofi India appoints Haresh Vala as Company Secretary, Compliance Officer

Sanofi intravitreal gene therapy wins USFDA fast track designation for geographic atrophy due to age-related macular degeneration

Ruchika Sharma16 July 2025 1:30 PM IST

Paris: Sanofi has received fast track designation from the US Food and Drug Administration (FDA) for SAR446597, a one-time intravitreal gene therapy...

Around 5,000 Small Pharma Units at Risk as Centre Enforces Tougher GMP Norms

Shilpa Medicare Dabaspet unit gets VAI classification from USFDA

Ruchika Sharma16 July 2025 12:14 PM IST

Karnataka: Shilpa Medicare Limited has received an Establishment Inspection Report (EIR) with Voluntary Action Indicated (VAI)...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok